SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059476
Filing Date
2023-11-06
Accepted
2023-11-06 16:42:03
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-20230930.htm   iXBRL 10-Q 2314423
2 EX-31.1 crsp-ex31_1.htm EX-31.1 12505
3 EX-31.2 crsp-ex31_2.htm EX-31.2 12505
4 EX-32.1 crsp-ex32_1.htm EX-32.1 11572
  Complete submission text file 0000950170-23-059476.txt   8178652

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20230930.xsd EX-101.SCH 45076
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20230930_lab.xml EX-101.LAB 393360
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crsp-20230930_def.xml EX-101.DEF 168861
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crsp-20230930_cal.xml EX-101.CAL 47969
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20230930_pre.xml EX-101.PRE 281756
54 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20230930_htm.xml XML 1611054
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 231380494
SIC: 2836 Biological Products, (No Diagnostic Substances)